{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:24:46Z","timestamp":1761863086690},"reference-count":19,"publisher":"Jaypee Brothers Medical Publishing","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.4103\/0972-5229.94433","type":"journal-article","created":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T16:10:18Z","timestamp":1332951018000},"page":"37-40","source":"Crossref","is-referenced-by-count":14,"title":["Use of intravenous immunoglobulin therapy in the treatment of septic shock, in particular severe invasive group A streptococcal disease"],"prefix":"10.5005","volume":"16","author":[{"given":"Ajay H.","family":"Raithatha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele C.","family":"Bryden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","published-online":{"date-parts":[[2012]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Davies DH, McGeer A, Schwartz B, Green K, Cann D, Simor AE, et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med 1996;335:547-54.","DOI":"10.1056\/NEJM199608223350803"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"O\u2032Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A et al. The Epidemiology of Invasive Group A Streptococcal Infections and Potential Vaccine Implications, United States, 2000-2004. Clin Infect Dis 2007;45:853-62.","DOI":"10.1086\/521264"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"I.V. immunoglobulin therapy for infectious diseases. Drug Ther Bull 2010;48:57-60.","DOI":"10.1136\/dtb.2009.07.0032"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome: a retrospective population-based study. JAMA 1993;269:384-9.","DOI":"10.1001\/jama.1993.03500030082037"},{"key":"ref=5","unstructured":"Streptococcal Toxic-Shock Syndrome (STSS), 2010 Case Definition. CSTE Position Statement Number: 09-ID-60. Centers for Disease Control and Prevention. Available from: http:\/\/www.cdc.gov\/. [Last accessed as on 2011 Aug 9]."},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Kivity S, Katz U, Daniel N, Nussinovitch U, Papageorgiou N, Shoenfeld Y. Evidence for the use of intravenous immunoglobulins- a review of the literature. Clin Rev Allergy Immunol 2010;38:201-69.","DOI":"10.1007\/s12016-009-8155-9"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Darenberg J, Ihendyane N, Sj\u00f6lin J, Aufwerber E, Haidl S, Follin P, et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: A European randomised, double-blind, placebo-controlled trial. Clin Infect Dis 2003;37:333-40.","DOI":"10.1086\/376630"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Kaul R, McGeer A, Norrby-Teglund A, Kotb M, Schwartz B, O\u2032Rourke K, et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome- a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis 1999;28:800-7.","DOI":"10.1086\/515199"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Shah SS, Hall M, Srivastava R, Subramony A, Levin JE. Intravenous immunoglobulin in children with streptococcal toxic shock syndrome. Clin Infect Dis 2009;49:1369-76.","DOI":"10.1086\/606048"},{"key":"ref=10","unstructured":"IVIg Guideline Development Group of the IVIg expert Working Group. Clinical Guidelines for Immunoglobulin Use. Department of Health Clinical guidelines for Immunoglobulin use, United Kingdom (DHUK), 2 nd ed. May 30;2008"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Turgeon AF, Hutton B, Fergusson DA, McIntyre L, Tinmouth AA, Cameron DW, et al. Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis. Ann Intern Med 2007;146:193-203","DOI":"10.7326\/0003-4819-146-3-200702060-00009"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Laupland KB, Kirkpatrick AW, Delaney A. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: A systematic review and meta-analysis. Crit Care Med 2007;35:2686-92.","DOI":"10.1097\/00003246-200712000-00002"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Kreymann KG, de Heer G, Nierhaus A, Kluge S. Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med 2007;35:2677-85.","DOI":"10.1097\/00003246-200712000-00001"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Werdan K, Pilz G, Bujdoso O, Fraunberger P, Neeser G, Schmieder RE, et al. Score-based immunoglobulin G therapy of patients with sepsis: The SBITS study. Crit Care Med 2007;35:2693-701.","DOI":"10.1097\/01.CCM.0000295426.37471.79"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Alejandria MM, Lansang MA, Dans LF, Mantaring JB. Intravenous immunoglobulin for treating sepsis and septic shock. Cochrane Database Syst Rev 2002;1:CD001090. [Last assessed as on 2010 Jan 3].","DOI":"10.1002\/14651858.CD001090"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Neilson AR, Burchardi H, Schneider H. Cost-effectiveness of immunoglobulin M-enriched immunoglobulin (Pentaglobulin) in the treatment of severe sepsis and septic shock. J Crit Care 2005;20:239-50.","DOI":"10.1016\/j.jcrc.2005.03.003"},{"key":"ref=17","unstructured":"Berlot G, Bacer B, Piva M, Lucangelo U, Viviani M. Immunoglobulins in sepsis. Advances in Sepsis 2007;6:41-6."},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 [published correction appears in Crit Care Med 2008;36:1394-6.","DOI":"10.1097\/01.CCM.0000298158.12101.41"},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"Esen F, Tugrul S. IgM-enriched Immunoglobulins in Sepsis. (Chapter). Intensive Care Medicine Annual Update 2009. Vincent JL: Editor. Springer-Verlag New York. Section III. P.102-110, DOI: 10.1007\/978-0-387-92278-2_10","DOI":"10.1007\/978-0-387-92278-2_10"}],"container-title":["Indian Journal of Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijccm.org\/doi\/pdf\/10.4103\/0972-5229.94433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T14:26:27Z","timestamp":1687357587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijccm.org\/doi\/10.4103\/0972-5229.94433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012]]}},"alternative-id":["10.4103\/0972-5229.94433"],"URL":"https:\/\/doi.org\/10.4103\/0972-5229.94433","relation":{},"ISSN":["0972-5229","1998-359X"],"issn-type":[{"value":"0972-5229","type":"print"},{"value":"1998-359X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}